Reduction of SUV39H1 by administration of its specific inhibitor, chaetocin, or genetic knockdown, leads to a loss of H3K9me3 and enhances inflammatory responses in COPD (28). Here, SUV39H1 is linked to chronic obstructive pulmonary disease.